Wednesday, August 20, 2014 Last update: 5:33 PM
FreshNews.com - All Company Technology News Since 1996

KCI Presents New Clinical and Economic Evidence at SAWC/WHS Spring 2014 Conference

Companies mentioned in this article: Kinetic Concepts, Inc.

SAN ANTONIO -- (BUSINESS WIRE) -- Kinetic Concepts, Inc. today announced ten poster presentations* reporting the results of KCI advanced wound healing therapies will be presented at The Symposium on Advanced Wound Care (SAWC) and Wound Healing Society (WHS) Spring 2014 conference in Orlando, Florida on April 25 – April 27.

The presentations report on the use of KCI advanced wound healing therapies and present compelling pre-clinical, clinical and health economic outcomes. In one retrospective analysis of a national claims database, authors found that patients treated with KCI NPWT systems had lower all-cause and wound-related costs and lower hospital re-admission rates than patients treated with competitor NPWT systems.

“These data reinforce the value our therapies offer to healthcare practitioners as they work to reduce cost of care and patient hospital stay,” said Ron Silverman, Chief Medical Officer, KCI. “We are excited to present these data personally to healthcare leaders at SAWC and add to the library of clinical evidence supporting our products.”

Another study presented the use of the CelluTome™ Epidermal Harvesting System for harvesting epidermal grafts used in a non-surgical operating room to treat diabetic foot ulcers, venous leg ulcers or postoperative wounds on patients who had failed standard wound care therapy for greater than 12 weeks. Authors reported that five of six wounds were closed without recurrence.

In a retrospective study of 82 patients, the use of negative pressure wound therapy with instillation (NPWTi – V.A.C. VeraFlo™ Therapy) was compared to traditional NPWT for the treatment of extremity and trunk wounds. Authors concluded automated NPWTi appeared to assist in wound cleansing and exudate removal, which may have allowed for earlier wound closure compared to standard NPWT. Findings from a hypothetical model also illustrated the potential cost effectiveness of NPWTi compared to NPWT in this patient population.

To learn more about KCI’s presence at SAWC/WHS Spring 2014, click here. To learn more about KCI therapies, including the CelluTome™ Epidermal Harvesting System, V.A.C. VeraFlo™ Therapy and V.A.C.® Therapy, visit www.KCI1.com.

About KCI

Kinetic Concepts, Inc. (KCI) is a leading global medical technology company devoted to understanding, developing and commercializing innovative, high-technology transformational healing solutions for customers and patients in more than 75 countries around the world. KCI, along with LifeCell Corporation and Systagenix Wound Management, form one globally diversified wound care, biologics and regenerative medicine company, committed to advancing the science of medicine to reduce complications, speed healing and improve patient lives. Headquartered in San Antonio, Texas, the company is a leader in the medical technology industry with the most comprehensive offering of best-in-class surgical and chronic wound therapies. Additional information about KCI and its products is available at www.KCI1.com.

*Posters presented at SAWC/WHS Spring 2014 Conference:

  • Negative pressure wound therapy (NPWT) systems: Ability to deliver prescribed negative pressure (NP) to the wound site. Deepak V. Kilpadi, PhD, MBA; Carrie Kauffman, AAS.
  • Negative pressure wound therapy systems: Ability to remove fluid from a simulated wound site. Deepak V. Kilpadi, PhD, MBA; Carrie Kauffman, AAS.
  • Healthcare Costs and Hospital Readmission Rates Associated With Negative Pressure Wound Therapies. Amy Law, MBA, Anissa Cyhaniuk, MA, Blake Kreb, MBA.
  • Real World Review of Tunneled Wounds in Patients Treated in US Wound Care Centers. Braden K. Leung, PhD, Roberta A. James, MStat.
  • Use of Negative Pressure Wound Therapy to Treat Pressure Ulcers: Review and Potential Economic Benefits. Andrew Stell, BBA, Julissa Ramos, PhD, Ricardo Martinez, MS.
  • Use of a Novel Epidermal Harvesting System to Produce Epidermal Micrografts for the Treatment of Chronic Pedal Wounds. L. Allen, DPM, MPH, M. Yao, MD, MPH, Elizabeth Bourret, DPM, V.R. Driver MS, DPM, FACFAS.
  • Cost Analysis of Negative Pressure Wound Therapy with Instillation for Wound Bed Preparation Preceding Split-Thickness Skin Grafts for Massive (>100 cm2) Chronic Venous Leg Ulcers. Sean Alcantara MD, Selena Goss MD, Jamie Schwartz MD, Cynthia Gendics RN, John Lantis MD.
  • Use of Negative Pressure Wound Therapy with Automated Volumetric Instillation for the Treatment of Extremity and Trunk Wounds: Clinical Outcomes and Potential Cost Effectiveness. Allen Gabriel MD and Amy Law, MBA.
  • The Efficacy of Negative Pressure Wound Therapy with Instillation and Split-Thickness Skin Grafting for Massive (>100 cm2) Chronic Venous Leg Ulcers. Sean Alcantara MD, Selena Goss MD, Jamie Schwartz MD, Cynthia Gendics RN, John Lantis MD.
  • Granulation Response of Negative Pressure Wound Therapy with Instillation Includes Gene Expression Variations While Maintaining Tissue Quality Compared to Continuous and Non-Continuous Negative Pressure Wound Therapy in a Porcine Model. Kathleen Derrick MS, Chris Lessing PhD, Diwi Allen MS, Roberta James MS, Shannon Ingram PE.


Copyright © Business Wire 2014
Contact:

KCI Corporate Communications
Mike Barger, +1-210-255-6824
mike.barger@kci1.com
or
KCI Investor Relations
Nathan Speicher, +1-210-255-6027
nathan.speicher@kci1.com